Tanya Turan to Fibrinolytic Agents
This is a "connection" page, showing publications Tanya Turan has written about Fibrinolytic Agents.
Connection Strength
2.186
-
Secondary Stroke Prevention and Management for the Neuro-Ophthalmologist. J Neuroophthalmol. 2020 12; 40(4):463-471.
Score: 0.565
-
Yet again no benefit of stenting over medical therapy. Lancet Neurol. 2015 Jun; 14(6):565-6.
Score: 0.383
-
Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis. 2014; 37(3):203-11.
Score: 0.353
-
Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke. 2009 Feb; 40(2):505-9.
Score: 0.247
-
Type and Duration of Exercise in the SAMMPRIS Trial. Neurologist. 2019 Jan; 24(1):10-12.
Score: 0.124
-
Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke. 2015 Mar; 46(3):775-9.
Score: 0.094
-
The challenge of stroke prevention with intracranial arterial stenosis. Curr Cardiol Rep. 2013 Dec; 15(12):422.
Score: 0.087
-
Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012 Dec; 43(12):3442-53.
Score: 0.079
-
10 questions about intracranial atherosclerotic stenosis. Neurologist. 2010 Nov; 16(6):400-5.
Score: 0.070
-
Treatment of atherosclerotic intracranial arterial stenosis. Stroke. 2009 Jun; 40(6):2257-61.
Score: 0.063
-
Treatment of intracranial atherosclerotic stenosis. Rev Neurol Dis. 2008; 5(3):117-24.
Score: 0.058
-
Stroke in pregnancy. Neurol Clin. 2004 Nov; 22(4):821-40.
Score: 0.046
-
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011 Jun; 69(6):963-74.
Score: 0.018